Wells Fargo Maintains Overweight on Dorman Products, Raises Price Target to $155
Dorman Products, Inc.
Dorman Products, Inc. DORM | 0.00 |
Wells Fargo analyst David Lantz maintains Dorman Products (NASDAQ:
DORM) with a Overweight and raises the price target from $140 to $155.